Skip to search formSkip to main contentSkip to account menu

MK 5442

Known as: MK-5442, MK5442 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

JTT 305

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
The quest for new drugs to prevent osteoporosis-related fractures
Abstract There is a need for the development of new drugs to prevent osteoporosis-related fractures. Fractures are projected to… 
2017
2017
Neue osteoanabole Therapien zur Behandlung der Osteoporose
Was ist neu? Sklerostin-Blockade durch Romosozumab Der monoklonale Antikörper Romosozumab neutralisiert Sklerostin, einen… 
2015
2015
A phase 2 study of MK-5442, a calcium-sensing receptor antagonist, in postmenopausal women with osteoporosis after long-term use of oral bisphosphonates
SummaryIn women with osteoporosis treated with alendronate for >12 months and oral bisphosphonates for >3 of the last 4 years… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)